Danish Originals S2 E8: Jørgen Klubien

In this episode of the art and business podcast Danish Originals, Danish musician and animator Jørgen Klubien talks about his parallel artistic paths, as a singer who rose to fame in Denmark with his band Danseorkestret in the 1980s, and as an animator with Disney Studios.

From Glendale, Los Angeles, in his home where he has lived since 2005, Danish musician and animator Jørgen Klubien talks about his parallel artistic paths, as a singer who rose to fame in Denmark with his band Danseorkestret in the 1980s, and as an animator with Disney Studios, where he made a mark on all the iconic films, from The Little Mermaid, The Lion King, Pocahontas, Mulan, A Bug’s Life, Toy Story 2, Cars, Shrek Forever After, to Dumbo.

Jørgen selects and discusses a work by Henri Matisse from the SMK collection. 

Listen to Danish Originals on Spotify.





  • How internationals can benefit from joining trade unions

    How internationals can benefit from joining trade unions

    Being part of a trade union is a long-established norm for Danes. But many internationals do not join unions – instead enduring workers’ rights violations. Find out how joining a union could benefit you, and how to go about it.

  • Internationals in Denmark rarely join a trade union

    Internationals in Denmark rarely join a trade union

    Internationals are overrepresented in the lowest-paid fields of agriculture, transport, cleaning, hotels and restaurants, and construction – industries that classically lack collective agreements. A new analysis from the Workers’ Union’s Business Council suggests that internationals rarely join trade unions – but if they did, it would generate better industry standards.

  • Novo Nordisk overtakes LEGO as the most desirable future workplace amongst university students

    Novo Nordisk overtakes LEGO as the most desirable future workplace amongst university students

    The numbers are especially striking amongst the 3,477 business and economics students polled, of whom 31 percent elected Novo Nordisk as their favorite, compared with 20 percent last year.